Chemoinformaics analysis of 8-hydroxyquinoline
Molecular Weight | 145.161 | nRot | 0 |
Heavy Atom Molecular Weight | 138.105 | nRig | 11 |
Exact Molecular Weight | 145.053 | nRing | 2 |
Solubility: LogS | -2.25 | nHRing | 1 |
Solubility: LogP | 1.9 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
nHA | 2 | APOL | 21.5996 |
nHD | 1 | BPOL | 8.16245 |
QED | 0.614 |
Synth | 1.756 |
Natural Product Likeliness | -0.304 |
NR-PPAR-gamma | 0.912 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.003 |
HIA | 0.018 |
CACO-2 | -4.483 |
MDCK | 0.0000298 |
BBB | 0.442 |
PPB | 0.852332 |
VDSS | 1.048 |
FU | 0.137647 |
CYP1A2-inh | 0.867 |
CYP1A2-sub | 0.589 |
CYP2c19-inh | 0.388 |
CYP2c19-sub | 0.456 |
CYP2c9-inh | 0.172 |
CYP2c9-sub | 0.861 |
CYP2d6-inh | 0.237 |
CYP2d6-sub | 0.784 |
CYP3a4-inh | 0.065 |
CYP3a4-sub | 0.219 |
CL | 10.778 |
T12 | 0.785 |
hERG | 0.016 |
Ames | 0.468 |
ROA | 0.484 |
SkinSen | 0.802 |
Carcinogencity | 0.289 |
EI | 0.986 |
Respiratory | 0.942 |
NR-Aromatase | 0.18 |
Antiviral | No |
Prediction | 0.759645 |